Cardinal Health Operating Income decreased by 28.0% to $509.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 30.3%, from $730.00M to $509.00M. Over 4 years (FY 2021 to FY 2025), Operating Income shows an upward trend with a 48.2% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Growth in operating income suggests that the core business is becoming more profitable and efficient.
The profit realized from a business's own operations after deducting operating expenses like wages, depreciation, and co...
This is a key metric for comparing the fundamental business performance of companies with different tax or debt structures.
operating_income| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $162.00M | $415.00M | -$950.00M | -$97.00M | $0.00 | $137.00M | -$119.00M | $572.00M | $137.00M | -$14.00M | $482.00M | $369.00M | $406.00M | $568.00M | $549.00M | $730.00M | $428.00M | $668.00M | $707.00M | $509.00M |
| QoQ Change | — | +156.2% | -328.9% | +89.8% | +100.0% | — | -186.9% | +580.7% | -76.0% | -110.2% | >999% | -23.4% | +10.0% | +39.9% | -3.3% | +33.0% | -41.4% | +56.1% | +5.8% | -28.0% |
| YoY Change | — | — | — | — | -100.0% | -67.0% | +87.5% | +689.7% | — | -110.2% | +505.0% | -35.5% | +196.4% | >999% | +13.9% | +97.8% | +5.4% | +17.6% | +28.8% | -30.3% |
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Pharmaceutical and Specialty Solutions | $484.00M | $530.00M | $531.00M | $662.00M | $535.00M | $667.00M | $687.00M | $784.00M |
| Other Segments | $110.00M | $104.00M | $118.00M | $134.00M | $160.00M | $166.00M | $179.00M | $179.00M |
| Cost of product sold | $49.00M | $8.00M | $18.00M | $39.00M | $70.00M | $46.00M | $37.00M | $25.00M |
| Total | $406.00M | $568.00M | $549.00M | $730.00M | $428.00M | $668.00M | $707.00M | $509.00M |
Medical, Pharmaceutical were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.